Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
0.00%
)
US TECH 100
23,588.80
(
-0.87%
)
Dow Jones
46,225.15
(
0.00%
)
Brent Oil
107.55
(
0.91%
)
Bitcoin
69,287.66
(
-2.74%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 164591

Thursday, 09/12/2013 7:07:14 AM

Thursday, September 12, 2013 7:07:14 AM

Post# of 257257
ABBV/ENTA—TURQUOISE-1 (the phase-3 trial in HCV/HIV co-infection) is now listed at clinicaltrials.gov:

http://clinicaltrials.gov/ct2/show/NCT01939197

Along with MALACHITE-1 and -2, TURQUOISE-1 is one of the three global phase-3 trials of ABBV/ENTA’s HCV regimen that will not be part of the initial NDA/MAA in 2Q14. Please see #msg-90408583 for details.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now